MRD Strategic Steering Working Group

The MRD Strategic Steering WG is working on defining the next MRD projects:

• Demonstrate MRD Clinical Utility: Launch a new WG to focus on demonstrating the clinical utility of MRD testing, complementing ongoing efforts on MRD clinical validation approaches.

• Support guideline integration: Develop recommendations and guidance to accelerate inclusion of solid tumor MRD intended uses in the NCCN Guidelines.

• Pursue Early Endpoint designation: Create a dedicated WG to advance MRD testing toward Early Endpoint status in adjuvant therapy trials, strengthening the link between MRD results and long-term patient outcomes.

• Support the new DLBCL working group efforts in developing frameworks and standards for MRD clinical implementation.